MARRONE BIO INNOVATIONS INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)
MARRONE BIO INNOVATIONS INC. reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) of -$32.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease · last filed 2022-05-13
- MARRONE BIO INNOVATIONS INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2022-03-31 was -$32.00K.
- MARRONE BIO INNOVATIONS INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2021-09-30 was $123.00K, a 38.50% decline year-over-year.
- MARRONE BIO INNOVATIONS INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2021-06-30 was $178.00K, a 70.33% decline year-over-year.
- MARRONE BIO INNOVATIONS INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2021-03-31 was -$134.00K.
- MARRONE BIO INNOVATIONS INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2021 was -$639.00K, a 243.60% decline from fiscal 2020.
- MARRONE BIO INNOVATIONS INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2020 was $445.00K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 4 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 12 month |
|---|---|---|---|---|---|
| 2022-03-31 | -$32.00K 10-Q · filed 2022-05-13 | ||||
| 2021-12-31 | -$639.00K 10-K/A · filed 2022-05-09 | ||||
| 2021-09-30 | $123.00K 10-Q · filed 2021-11-10 | $301.00K derived: sum of 2 quarters · filed 2021-11-10 | $167.00K derived: sum of 3 quarters · filed 2021-11-10 | $49.00K derived: sum of 4 quarters · filed 2022-05-09 | |
| 2021-06-30 | $178.00K 10-Q · filed 2021-11-10 | $44.00K derived: sum of 2 quarters · filed 2021-11-10 | -$74.00K derived: sum of 3 quarters · filed 2022-05-09 | $126.00K derived: sum of 4 quarters · filed 2022-05-09 | |
| 2021-03-31 | -$134.00K 10-Q · filed 2021-11-10 | -$252.00K derived: sum of 2 quarters · filed 2022-05-09 | -$52.00K derived: sum of 3 quarters · filed 2022-05-09 | $548.00K derived: sum of 4 quarters · filed 2022-05-09 | |
| 2020-12-31 | -$118.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-09 | $82.00K derived: sum of 2 quarters · filed 2022-05-09 | $682.00K derived: sum of 3 quarters · filed 2022-05-09 | $445.00K 10-K/A · filed 2022-05-09 | |
| 2020-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $800.00K derived: sum of 2 quarters · filed 2020-11-09 | $563.00K 10-Q · filed 2020-11-09 | ||
| 2020-06-30 | $600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $363.00K 10-Q · filed 2020-08-10 | |||
| 2020-03-31 | -$237.00K 10-Q · filed 2020-05-11 | ||||
| 2019-12-31 | $342.00K 10-K · filed 2021-03-23 |